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stabbingRepetitive transcranial magnetic stimulation (rTMS) is a prom-
ising treatment for major depressive disorder [1]. Recently, we
investigated 10 sessions of high-frequency rTMS applied to the
left dorsolateral prefrontal cortex (DLPFC) in chronic stroke survi-
vors with depression (randomised controlled trial;
ACTRN12619001303134; institutional ethics approval 200697).
Stimulation was delivered at 110% resting motor threshold at 10
Hz for a total of 3000 pulses. Here we report the experience of a
51-year-old male with mild upper-limb impairment (Fugl-Meyer
49/66; structural imaging Fig. 1), who experienced anatomically
confined stimulus-evoked dental pain in response to sham
stimulation.
Prior to inclusion, the participant was screened for brain stimu-
lation safety [2]. There were no contraindications and no note-
worthy medical history beyond a stroke three years prior. Current
medications were anti-depressants and anti-coagulants with
dosage stable for more than 6-months. The participant had previ-
ously participated in transcranial direct current stimulation
research more than two months prior with no adverse events
beyond standard transient symptoms documented in the literature
[3]. Therefore, the participant was deemed safe for rTMS, included
in the trial and was progressed to full initial assessment.
After initial assessment, the participant was informed that there
was an active and sham condition in this trial and that he would be
blinded to allocation. He was randomised to receive sham rTMS.
The session began at 10:30am. Threshold of the left motor cortex
was 52% maximal stimulator (Magstim Super Rapid) output using
a Magstim 70mm Fig. 8 air film coil (part-number 3910-23-00).
Sham rTMSwas delivered with aMagstim 70mm Fig. 8 air film pla-
cebo coil (part-number 3950-23-00) to the left DLPFC at 57%
maximal stimulator output. Immediately upon delivery of sham
rTMS, he recoiled his head away from the stimulation coil and re-
ported strong pain on the left side of his face. Stimulation was
immediately stopped. Pain resolved almost instantly. On furthers article under the CC BY-NC-ND ling, the participant described the discomfort as a strong
pain in his upper and lower teeth, posterior to his left in-
cisors, and extending into and along his mandible. Several attempts
were made to optimise coil position or adjust stimulation intensity
(down to 50%). However, the same pain occurred with each stimu-
lation and resolved immediately. That is, the pain appeared to be
directly evoked by sham rTMS over the left DLPFC. No other sensory
or motor symptoms were reported; no motor signs were observed.
On further questioning, the participant recalled that two weeks
earlier he had undergone a dental procedure that included a filling
to a left upper molar. He had not raised this earlier because it did
not appear relevant and it had not been associated with symptoms
then or since.
There are very few published reports of adverse events during or
following sham rTMS. One study reported a toothache in a partici-
pant with depression following sham rTMS, but the time course,
distribution and type of pain was not clear [1]. There was also no
mention of dental procedures, oral and maxillofacial pathology,
nor additional neurological pathologies. There are reports of face
pain in response to active rTMS. For example, one study reported
that a patient experienced tooth pain (location not specified)
following active rTMS to the left DLPFC [4]. The treatment was
ceased to alleviate the pain. Another patient report, again involving
left DLPFC high-frequency rTMS, described a local ‘dental twinge’
near the upper left jaw that disappeared during the inter-train in-
terval and diminished over the course of treatment [5]. The authors
attributed the pain to “local irritation of the superficial temporal
portion of the trigeminal nerve by the pulsating magnetic fields
and projection via the N. buccalis into the dental region” [5].
Although the location of stimulation is consistent between those
rTMS cases and the current sham rTMS case, raising the possibility
that similar mechanisms are involved, we suspect that sensitisation
within, or upstream, from the trigeminal (sub-caudate) nucleus is a
more likely explanation and raises interesting possibilities for
future investigation outside of the neuromodulation field.
Sensitisation within the trigeminal nucleus, most obviously via
non-associative learning and activation of neuroinflammatory
and vasoactive cells, will decrease the activation threshold of sec-
ond order nociceptors. This has long been the primary aetiological
model for trigeminal neuralgia [6,7]. The central changes are often
attributed to injury, pathogenic invasion, compression or dystrophy
of the trigeminal nerve [8]. The bioresonance theory suggests that
certain frequency non-noxious peripheral input can trigger second
order nociceptors [9]. Upstream, altered thalamo-cortical connec-
tivity and default mode network changes have been identified in
those with trigeminal neuralgia and proposed as possible causesicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Structural magnetic resonance imaging in the axial plan demonstrating a significant right hemispheric lesion. Top row, T1 weighted images (MPRAGE, voxel
1 mm  1 mm  1mm, repetition time 2300 ms, echo time 2.98 ms, flip angle 9). Bottom row, T2 fluid-attenuated inversion recovery images (voxel 0.5 mm  0.5 mm  0.5mm,
repetition time 5000 ms, echo time 393 ms).
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of one branch of the trigeminal nerve may be sufficient to evoke
pain in the distribution of another.
According to Magstim, its sham rTMS coil (part-number 3950-
23-00) produces an electromagnetic field strength of <0.3T. This
is much lower than that produced by the active rTMS coil (0.8T,
part-number 3910-23-00) and thought insufficient to stimulate
the cortex, but may well be sufficient to activate trigeminal effer-
ents under the coil. That this appeared to trigger trigeminal
neuralgia-like pain in our participant raises an interesting opportu-
nity: could we have identified a pre-clinical sign of trigeminal neu-
ralgia? The participant did report dental work two weeks earlier
which, although without symptoms, may have initiated local irrita-
tion. Alternatively, perhaps the recognised causes of trigeminal
neuralgia e dystrophy, compression or disease of the peripheral
nerve e were underway in this participant but not yet causing
spontaneous symptoms. Of course, we cannot ignore the fact that
this participant had sustained a stroke, but we can see no clear
mechanisms by which his stroke would impart this effect.
We have reported this adverse event for three reasons: our
experience clearly shows that ipsilateral face pain is possible with
sham rTMS and other researchers should be aware of this possibil-
ity; it may be prudent for future studies targeting the DLPFC to
carefully question participants about recent dental pathologies or
procedures; the potential of non-physiological stimulation such
as that involved in sham or real TMS to identify pre-clinical trigem-
inal neuralgia seems worthy of exploration.Acknowledgements
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